Patents
Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273)
02/2008
02/07/2008US20080032340 Peptide motifs for binding avidin or neutravidin
02/07/2008US20080032318 Fret protease assays for clostridial toxins
02/07/2008US20080031954 Modulation of angiogenesis by a-beta peptide fragments
02/07/2008US20080031888 Tumor antigens
02/07/2008US20080031812 Redox-stable, non-phosphorylated cyclic peptide inhibitors of sh2 domain binding to target protein, conjugates, thereof, compositions and methods of synthesis and use
02/07/2008DE102006035899A1 New polysaccharide-peptide-conjugate, where the peptide portion contains a sequence having a signal group that is splittable by thrombin at its carbon-terminal end, useful in a procedure for determining the thrombin generation in a sample
02/07/2008CA2659875A1 Multifunctional bioactive compounds
02/06/2008EP1884775A1 Method for diagnosis of a disease involving an anti-AT1-receptor antibody
02/06/2008EP1884520A2 Daptomycin analogs as antibacterial agents
02/06/2008CN101120014A Modulation of ovulation
02/06/2008CN101120012A Metabolites of cyclosporin analogs
02/06/2008CN101116742A Non-aqueous polar aprotic peptide formulations comprising lhrh-related compounds
02/06/2008CN100366633C Antiviral polypeptide from Zongdian Tuanwa frog and its application in pharmacy
02/05/2008US7326767 Immunotherapeutic methods using epitopes of WT-1 and GATA-1
02/05/2008US7326707 Bicyclic melanocortin-specific compounds
02/05/2008US7326686 Compounds and methods for regulating cell adhesion
02/05/2008US7326685 Diagnostic or therapeutic somatostatin or bombesin analog conjugates and uses thereof
02/05/2008US7326684 Peptides for enhancing resistance to microbial infections
02/05/2008US7326682 Conotoxin peptides
02/05/2008US7326566 Compositions and methods for screening antimicrobials
02/05/2008US7326425 Biologically active compound hydrogen bonded to a first polyester containing tyrosine-derived diphenol units blended with a second polymer that degrades to promote the release of the active compound
02/05/2008CA2218161C Peptide compositions with growth factor-like activity
02/05/2008CA2166155C Agents binding to hyaluronic acid binding domains and the use thereof
02/05/2008CA2165039C Cyclohexapeptides and their mixtures, a process for preparing them, and their use
02/05/2008CA2136339C Derivatives of dolastatin
02/05/2008CA2124953C Peptides related to prion proteins
01/2008
01/31/2008WO2008012102A2 Radiodense conjugate
01/31/2008WO2008012086A2 Protein-binding methotrexate derivatives, and medicaments containing the same
01/31/2008WO2007122488A3 Radiofluorinated compounds and their preparation
01/31/2008WO2007096855A3 Angiotensin-i-converting enzyme inhibitory
01/31/2008US20080027148 Drug targets related to synthase subfamily; alternative splice forms; isolated peptides and antibodies
01/31/2008US20080027006 Compositions And Methods For Modification And Prevention Of Sars Coronavirus Infectivity
01/31/2008US20080027003 Peptides Useful for Treating Gnrh Associated Diseases
01/31/2008US20080027001 Nogo receptor functional motifs, peptide mimetics, and mutated functional motifs related thereto, and methods of using the same
01/31/2008US20080026992 Tyrosine Phosphorylation of Cdk Inhibitor Proteins of the Cip/Kip Family
01/31/2008US20080026990 18-Membered Nitrobenzyl- and Aminobenzyl-Substituted Cyclohexadepsipeptides for Controlling Endoparasites and a Process for Their Preparation
01/31/2008US20080026427 HUMAN cDNAs AND PROTEINS AND USES THEREOF
01/31/2008US20080025971 Antibody comprising a human heavy chain framework sequence, three heavy chain hypervariable region sequences and three light chain hypervariable region sequences; modulating biological activity of integrins containing the beta7 subunit
01/31/2008DE102006035577A1 Röntgendichtes Konjugat Radiopaque conjugate
01/31/2008CA2659225A1 Immunogenic compounds and protein mimics
01/31/2008CA2595158A1 Polysaccharide-peptide conjugates for use as thrombin substrates
01/30/2008EP1399471B1 Use of dipeptidyl peptidase iv inhibitors as therapeutics for neurological disorders
01/30/2008CN101113164A 12 peptide specifically combined with tumor metastasis related protein PRL-3 and uses thereof
01/30/2008CN101113163A Hla-a24-restricted cancer antigen peptides
01/30/2008CN100365016C Series peptide for promoting proliferation of bone marrow karyota and bone marrow substrate cell and its application
01/30/2008CN100365015C 12-mer peptide, compound containing the same, its preparation method and application in cancer treatment drug
01/30/2008CN100365014C Tumor targeting agents and uses thereof
01/30/2008CN100364606C Peptide compositions and formulations and use of same
01/29/2008US7323542 Bioactive amino acid sequences conjugated with biocompatible, biodegradable delivery system for use in treatment and prevention of bone disorders: prosthetics
01/29/2008US7323444 Use of kahalalide compounds for the manufacture of a medicament for the treatment of psoriasis
01/29/2008US7323174 Modulation of immune response and methods based thereon
01/29/2008CA2471775C Targeted cytotoxic anthracycline analogs
01/29/2008CA2295321C Isolated nona- and decapeptides which bind to hla molecules, and the use thereof
01/29/2008CA2237721C Antineoplastic peptides
01/24/2008WO2008010098A2 Identification, optimization and use of cryptic hla-b7 epitopes for immunotherapy
01/24/2008WO2008010010A1 Identification, optimization and use of cryptic hla-b7 epitopes for immunotherapy
01/24/2008WO2008009895A2 Matriptase-2
01/24/2008WO2008009672A1 Process for the manufacture of peptides
01/24/2008WO2008009085A1 Anti-inflammatory and antiallergic cyclic peptides
01/24/2008WO2007072063A3 A bioassay and peptides for use therein
01/24/2008WO2007021661A3 Ligands of sh3 domains
01/24/2008WO2004081188A3 Non-toxic membrane-translocating peptides
01/24/2008US20080021199 Methods for the specific preparation of lysobactin fragments
01/24/2008US20080021198 Modulators of protein phosphatase 2A and PP2A methyl esterase
01/24/2008US20080021197 reacting an acetyl cyclosporin aldehyde with an organozirconium reagent (Cp2Zr(H)Cl) to provide acetyl cyclosporin diene (the acetate of trans ISATX247) and deacetylating the acetyl cyclosporin diene to produce the trans-isomer of ISATX247; immunosuppressant
01/24/2008US20080020979 Peptides of Syndecan-1 For Inhibiting Angiogenesis
01/24/2008US20080020970 For promoting the release of growth hormone and of enhancing wound healing in a human or animal subject; for treating short stature, cachexia, wasting, type 2 diabetes, and poor circulation
01/24/2008US20080020377 Peptide-Based Method for Monitorting Gene Expression in a Host Cell
01/24/2008US20080019994 Immunization Against Chlamydia Infection
01/24/2008US20080019992 Antigen mimotopes and vaccine against cancerous diseases
01/24/2008US20080019913 Enkepahlin analogs with improved bioavailability
01/24/2008CA2657338A1 Anti-inflammatory and antiallergic cyclic peptides
01/24/2008CA2656883A1 Identification, optimization and use of cryptic hla-b7 epitopes for immunotherapy
01/23/2008EP1881008A1 Method for the in vitro diagnosis of alzheimer's disease using a monoclonal antibody
01/23/2008EP1881006A1 Parathyroid hormone analogues for the treatment of osteoporosis
01/23/2008EP1881003A1 Compound having amino acid residue or peptide residue and process for producing the same
01/23/2008EP1880736A1 Releasable linkage and composition containing same
01/23/2008EP1880007A2 Personal care compositions and methods for their use
01/23/2008EP1879911A1 Dye conjugates of template-fixed peptidomimetics
01/23/2008EP1436316B1 Subcellular targeting of therapeutic proteins
01/23/2008CN101111513A Glycopeptide antibiotic monomer derivative
01/23/2008CN101111510A On-resin peptide cyclization
01/23/2008CN101111258A Emulsified composition for dilution and cancer vaccine composition
01/23/2008CN101111257A Methods of increasing cerebral blood flow
01/23/2008CN101108875A Growth hormone releasing peptides
01/23/2008CN100363383C Micro-molecular polypeptides capable of combining with gold staphylococcus virulence factor regulatory protein and its pharmaceutical use
01/22/2008US7320959 Transgenic aniomal nmodels; screening; administering peptide
01/22/2008CA2380569C Chimeric polypeptides, method for production and uses thereof
01/17/2008WO2008007711A1 Sart3-derived peptide useful in cancer vaccine therapy for hla-a3 supertype allele-positive prostate cancer patient
01/17/2008WO2007134127A3 Agents for imaging apoptosis
01/17/2008WO2007064759A3 Inhibiting tumour cell invasion, metastasis and angiogenesis through targetting legumain
01/17/2008WO2007035474A3 Transdermal delivery peptides and method of use thereof
01/17/2008WO2006105490A3 Compositions and methods for treating diseases associated with phlpp
01/17/2008US20080015164 Methods and compositions for inactivation of dihydrofolate reductase
01/17/2008US20080015152 Therapeutic amino acid sequences for use in treatment and prevention of viral, infectious, cancerous, diabetic, incontinent, hypertensive, eating and nervous system disorders
01/17/2008US20080015150 Peptides and Derivatives Thereof Showing Cell Attachment, Spreading and Detachment Activity
01/17/2008US20080014636 inducer of cytotoxic T cells; use of a tumor antigen protein PBF and a gene encoding the same cancer immunology; tumor marker
01/17/2008US20080014209 Peptide mimics of conserved Gonococcal epitopes and methods and compositions using them
01/17/2008US20080014186 Hla-A24 or Hla-A2 Binding Peptides of Parathyroid Hormone-Related Protein
01/17/2008CA2657665A1 Method and compositions for treating stroke with fever